June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
The effects of a red light technology on dry eye due to meibomian gland dysfunction
Author Affiliations & Notes
  • Rolando Toyos
    Toyos Clinic, Germantown, Tennessee, United States
  • Footnotes
    Commercial Relationships   Rolando Toyos, Lumenis (C), Shire (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2236. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rolando Toyos; The effects of a red light technology on dry eye due to meibomian gland dysfunction
      . Invest. Ophthalmol. Vis. Sci. 2017;58(8):2236. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : With a high prevalence of dry eye due to meibomian gland dysfunction (MGD) in the general population, effective methods of treatment are becoming very important. The purpose of this study is to present data on the effectiveness of the use of a red light technology called the Quantum (or Q). This Q was developed as an at home therapy to directly affect the meibomian gland secretions and thereby alleviate the symptoms of dry eye.

Methods : This prospective study measured non-invasive break up time (NIBUT) with the Oculus Keratograph before and after treatment with the Q. Patients were selected based on dry eye symptoms, NIBUT less than 10 sec, and clinical observation of MGD. Patients were instructed to place the Q over closed eyes for 3 minutes on each eye at least twice a week. Patients could not use the Q more than once a day. 52 patients were included in the study and treatment times ranged from 1 to 12 months.

Results : NIBUT data before and after treatment was achieved on 81 eyes. The mean NIBUT before treatment was 3.62 sec with a standard deviation of 2.05. Values ranged from 0.9 sec to 8.54 sec. Mean NIBUT post treatment was 5.87sec with a standard deviation of 2.95. Values ranged from 1.5 sec to 16.19 sec. T-test results show the difference to be statistically significant (P <0.001). No statistical significance found between right eyes (N=41) and left eyes (N=40) before treatment (P=0.53) or after treatment (P=0.75).

Conclusions : On average, at home use of the Q shows a statistically significant improvement in NIBUT. This prototype has been developed over several years and once ready for public distribution may be dispensed by physicians in treating evaporative dry eye due to MGD as an alternative to oral and topical medications.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.